FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/05/2026
Voltar para busca
Dado oficial do USPTO
BEYOND CDMO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BEYOND CDMO
ST13
US500000079407434Classe
1, 9, 42
Pedido
79407434
Registro
8131585
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
11/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 9, 42
Data de depósito
28/06/2024
Data de registro
10/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/02/2026
Última transação
11/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SE
Examinador
BEVERLY, JOSETTE MICHELLE
Unidade examinadora
M60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
NorthX Biologics AB
Representantes
Alexander Lazouski Lazouski IP LLC
Classificação técnica
Classes Nice
Classe 1Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and scienceespecially proteinsenzymes and modifications thereof.
Classe 9
Scientific apparatus and instruments being medical laboratory research instruments for controllingmeasuringacceleratingtransporting chemicals for use in biochemical and genetic research; Scientific apparatus and instrumentsapparatus and instruments being medical laboratory research instruments for use in gene therapyplasmid DNA productioncell banking and DNA sequencing
Classe 42
Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research servicestechnology advisory services related to pharmaceutical research and developmentdevelopment of gene therapy productsgenetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific researchconducting clinical trials for others; medical and scientific researchconducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/03/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
23/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/02/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/12/2025
PUBO
PUBLISHED FOR OPPOSITION
23/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/11/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/11/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
26/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/11/2025
RFNT
REFUSAL PROCESSED BY IB
12/09/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/08/2025
RFRR
REFUSAL PROCESSED BY MPU
26/08/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/08/2025
CNRT
NON-FINAL ACTION WRITTEN
25/08/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
24/02/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/01/2025
CNRT
NON-FINAL ACTION WRITTEN
08/01/2025
DOCK
ASSIGNED TO EXAMINER
26/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
24/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/10/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BEYOND CDMO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.